RESUMO
BACKGROUND: In the nearly half century since it began lending for population projects, the World Bank has become one of the largest financiers of global health projects and programs, a powerful voice in shaping health agendas in global governance spaces, and a mass producer of evidentiary knowledge for its preferred global health interventions. How can social scientists interrogate the role of the World Bank in shaping 'global health' in the current era? MAIN BODY: As a group of historians, social scientists, and public health officials with experience studying the effects of the institution's investment in health, we identify three challenges to this research. First, a future research agenda requires recognizing that the Bank is not a monolith, but rather has distinct inter-organizational groups that have shaped investment and discourse in complicated, and sometimes contradictory, ways. Second, we must consider how its influence on health policy and investment has changed significantly over time. Third, we must analyze its modes of engagement with other institutions within the global health landscape, and with the private sector. The unique relationships between Bank entities and countries that shape health policy, and the Bank's position as a center of research, permit it to have a formative influence on health economics as applied to international development. Addressing these challenges, we propose a future research agenda for the Bank's influence on global health through three overlapping objects of and domains for study: knowledge-based (shaping health policy knowledge), governance-based (shaping health governance), and finance-based (shaping health financing). We provide a review of case studies in each of these categories to inform this research agenda. CONCLUSIONS: As the COVID-19 pandemic continues to rage, and as state and non-state actors work to build more inclusive and robust health systems around the world, it is more important than ever to consider how to best document and analyze the impacts of Bank's financial and technical investments in the Global South.
Assuntos
Conta Bancária/organização & administração , Financiamento da Assistência à Saúde , Pesquisa Translacional Biomédica/métodos , Conta Bancária/tendências , Administração Financeira , Saúde Global , Política de Saúde , Humanos , Pesquisa Translacional Biomédica/organização & administraçãoAssuntos
Saúde Global , Direitos Humanos , Política de Saúde , Humanos , Liderança , Formulação de PolíticasAssuntos
Assistência Integral à Saúde/tendências , Consenso , Reforma dos Serviços de Saúde/tendências , Atenção Primária à Saúde/tendências , Assistência Integral à Saúde/organização & administração , Saúde Global , Reforma dos Serviços de Saúde/legislação & jurisprudência , Humanos , Internacionalidade , Atenção Primária à Saúde/legislação & jurisprudência , Atenção Primária à Saúde/organização & administraçãoAssuntos
Serviços de Saúde da Criança/organização & administração , Apoio Financeiro , Acessibilidade aos Serviços de Saúde/organização & administração , Serviços de Saúde Materna/organização & administração , Criança , Serviços de Saúde da Criança/economia , Países em Desenvolvimento , Feminino , Saúde Global , Acessibilidade aos Serviços de Saúde/economia , Humanos , Recém-Nascido , Serviços de Saúde Materna/economia , Gravidez , Organização Mundial da SaúdeRESUMO
In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members. Respondents were told that two doses of the vaccine would be required 2 weeks apart, and that the cholera vaccine would offer excellent protection against infection for the first year following vaccination, and some protection during the second and third year after a person is vaccinated. This research was carried out in order to learn more about private demand for vaccines in a cholera-endemic area. We asked two types of valuation questions: (1) a discrete-price offer for a vaccine that could be purchased for household members and (2) a payment card designed to assess uncertainty in the respondent's demand for a vaccine for self-protection. We estimate average household willingness to pay (WTP) for cholera vaccines in Beira to be 2005 US$ 8.45. This estimate of household WTP represents the perceived private economic benefits to a household--six persons on average--of giving all members free cholera vaccines.
Assuntos
Vacinas contra Cólera/administração & dosagem , Vacinação/economia , Vacinas contra Cólera/economia , Custos e Análise de Custo , Humanos , MoçambiqueRESUMO
We conducted a study to assess the feasibility and the potential vaccine coverage of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban endemic neighbourhood of Beira, Mozambique. The campaign was conducted from December 2003 to January 2004. Overall 98,152 doses were administered, and vaccine coverage of the target population was 58.6% and 53.6% for the first and second rounds, respectively. The direct cost of the campaign, which excludes the price of the vaccine, amounted to slightly over 90,000 dollars, resulting in the cost per fully vaccinated person of 2.09 dollars, which is relatively high. However, in endemic settings where outbreaks are likely to occur, integrating cholera vaccination into the routine activities of the public health system could reduce such costs.
Assuntos
Cólera/epidemiologia , Vacinação em Massa , Administração Oral , Adolescente , Criança , Pré-Escolar , Cólera/prevenção & controle , Custos e Análise de Custo , Feminino , Humanos , Masculino , Vacinação em Massa/economia , Moçambique/epidemiologiaRESUMO
Health research can play an important part in achieving the goals of improving health, economic development and reducing poverty, even though a review of the literature suggests that little attention is given to the subject. Mozambique as a developing country has scarce resources for health research and so its health research efforts need targeted at pressing concerns and be capable of influencing policy-making. A way forward is being developed so that position of policy-makers and researchers is clarified and co-ordination better organised. This will also involve a review of financing, formulation of agendas, the avoidance of wasted resources and improving management skills.